{"disease":{"id":"at-least-one-positive-lesion-according-to-the-2014-lugano-criteria-for-hodgkin-s-and-non-hodgkin-s-lymphoma","name":"at least one positive lesion according to the 2014 lugano criteria for hodgkin s and non hodgkin s lymphoma"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05050630","title":"Phase II Trial of Tirelizumab Combined With R2-ICE Regimen in the Treatment of rrDLBCL/HGBL","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":73,"lead_sponsor_name":"Affiliated Hospital to Academy of Military Medical Sciences","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}